Pei-Jie Huang

Title: Pei-Jie Huang: Innovator in Thyroid Cancer Prognosis

Introduction

Pei-Jie Huang is a distinguished inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the prognosis of thyroid cancer. His innovative approach has the potential to improve patient outcomes through non-invasive methods.

Latest Patents

Pei-Jie Huang holds a patent for a groundbreaking method related to thyroid cancer prognosis. The patent, titled "Biomarker for prognosis of thyroid cancer," outlines a method that involves obtaining an exosome from a subject who has undergone therapy for thyroid cancer, such as thyroidectomy. The method includes detecting the presence of thyroglobulin in the exosome. This innovative approach provides a non-invasive, reproducible, convenient, serial, and accurate follow-up marker for patients with thyroid cancer.

Career Highlights

Pei-Jie Huang is affiliated with National Taiwan University, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential to transform the way thyroid cancer is monitored and treated.

Collaborations

Pei-Jie Huang collaborates with esteemed colleagues, including Chih-Yuan Wang and Tien-Chun Chang. Their combined expertise enhances the research efforts and fosters innovation in the field of cancer prognosis.

Conclusion

Pei-Jie Huang's contributions to thyroid cancer prognosis exemplify the impact of innovative research in medicine. His patent and ongoing work at National Taiwan University highlight the importance of non-invasive methods in improving patient care.